Primary |
Plasmapheresis |
14.3% |
Hepatic Failure |
9.5% |
Hyponatraemia |
9.5% |
Hypotension |
9.5% |
Hypovolaemia |
9.5% |
Urine Output Decreased |
9.5% |
Coronary Artery Bypass |
4.8% |
Hypoalbuminaemia |
4.8% |
Kawasaki's Disease |
4.8% |
Oedema |
4.8% |
Pleural Effusion |
4.8% |
Product Used For Unknown Indication |
4.8% |
Shock Haemorrhagic |
4.8% |
Volume Blood Decreased |
4.8% |
|
Off Label Use |
8.7% |
Polyuria |
8.7% |
Urticaria |
8.7% |
Blood Pressure Decreased |
4.3% |
Blood Pressure Increased |
4.3% |
Cardiac Failure |
4.3% |
Cardio-respiratory Arrest |
4.3% |
Complications Of Transplanted Heart |
4.3% |
Heart Rate Increased |
4.3% |
Hypotension |
4.3% |
Laboratory Test Abnormal |
4.3% |
Myelodysplastic Syndrome |
4.3% |
Procedural Complication |
4.3% |
Pulmonary Congestion |
4.3% |
Pulmonary Oedema |
4.3% |
Renal Impairment |
4.3% |
Respiratory Rate Increased |
4.3% |
Shock |
4.3% |
Suspected Transmission Of An Infectious Agent Via Product |
4.3% |
Volume Blood Increased |
4.3% |
|
Secondary |
Plasmapheresis |
66.7% |
Hypotension |
33.3% |
|
Blood Pressure Decreased |
33.3% |
Cardiac Failure |
33.3% |
Complications Of Transplanted Heart |
33.3% |
|
Concomitant |
Prophylaxis |
20.1% |
Castleman's Disease |
16.2% |
Drug Use For Unknown Indication |
14.7% |
Constipation |
6.9% |
Product Used For Unknown Indication |
6.4% |
Insomnia |
5.0% |
Renal Failure |
3.8% |
Hypertension |
3.3% |
Hyperuricaemia |
2.5% |
Small Intestine Carcinoma |
2.2% |
Surgery |
2.2% |
Pneumonia |
2.1% |
Abdominal Pain |
1.9% |
Glaucoma |
1.9% |
Haemorrhoids |
1.9% |
Thrombosis Prophylaxis |
1.9% |
Cardiac Failure |
1.8% |
Arteriosclerosis Obliterans |
1.6% |
Post Herpetic Neuralgia |
1.6% |
Prophylaxis Against Transplant Rejection |
1.6% |
|
White Blood Cell Count Decreased |
14.6% |
Cerebral Infarction |
8.3% |
Vomiting |
7.3% |
Neutrophil Count Increased |
6.3% |
Platelet Count Decreased |
6.3% |
Pleurisy |
6.3% |
Cardiac Failure |
5.2% |
Transplant Rejection |
5.2% |
Visual Field Defect |
5.2% |
Renal Impairment |
4.2% |
Stomatitis |
4.2% |
Thrombocytopenia |
4.2% |
Dyspnoea |
3.1% |
Pulmonary Artery Thrombosis |
3.1% |
Renal Failure |
3.1% |
Toxic Epidermal Necrolysis |
3.1% |
Vasculitis |
3.1% |
Ventricular Tachycardia |
3.1% |
Cholecystitis |
2.1% |
Diarrhoea |
2.1% |
|